Atypical Plasma Cell Leukemia Mistaken for Acute Leukemia: A Case Report.
acute leukemia
flow cytometry
immunohistochemistry
immunophenotype
plasma cell leukemia
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
20 Aug 2024
20 Aug 2024
Historique:
received:
13
07
2024
revised:
31
07
2024
accepted:
07
08
2024
medline:
1
9
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
The patient we present here had many clinical, morphological, and laboratory findings characteristic of acute leukemia. During the course of the disease, the diagnosis changed from acute leukemia to chronic small B-cell lymphoproliferative disease, a blastoid variant of mantle cell lymphoma, and finally to atypical plasma cell leukemia. Atypical plasma cell leukemia is a rare condition with aggressive biological behavior. Our patient relapsed a short time after achieving complete remission, in spite of aggressive therapy and autologous stem cell transplantation. During relapse, it was possible to morphologically identify malignant cells as being of plasma cell origin, although immature and atypical. Atypical plasma cell leukemia presents a diagnostic challenge as it may mimic other neoplasms both morphologically and clinically. It is also recognized that plasma cell neoplasm immunophenotype may not be entirely specific for its lineage where common diagnostic biomarkers are applied by immunohistochemistry or flow cytometry. Where this is the case, only focused investigation for plasma cell lineage will be more informative. This patient has unusual clinical presentation, a nondescript morphology of the circulating plasma cells, as well as an immunophenotype, detected by the initial panels used for flow cytometry and immunohistochemistry, that was not entirely specific for plasma cells. Such cases present a good reminder of the diagnostic complexity of atypical plasma cell leukemia and emphasize that plasma cell differentiation needs to be interrogated in cases where the initial work-up shows unusual results.
Identifiants
pubmed: 39202633
pii: medicina60081351
doi: 10.3390/medicina60081351
pmc: PMC11356772
pii:
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Blood Cancer J. 2021 Dec 2;11(12):192
pubmed: 34857730
Diagn Cytopathol. 2015 Feb;43(2):158-62
pubmed: 24828023
Leukemia. 2022 Jul;36(7):1703-1719
pubmed: 35732831
Indian J Hematol Blood Transfus. 2009 Jun;25(2):81-3
pubmed: 23100981
Intern Med. 2019 Aug 1;58(15):2213-2217
pubmed: 30996175
Clin Epidemiol. 2016 Oct 25;8:583-587
pubmed: 27822103
Mayo Clin Proc. 2021 Mar;96(3):677-687
pubmed: 33673918
Expert Rev Hematol. 2019 Apr;12(4):245-253
pubmed: 30905220
Clin Lab Med. 1991 Jun;11(2):469-99
pubmed: 1873967
Leuk Lymphoma. 2004 Nov;45(11):2281-9
pubmed: 15512818
Blood. 2020 Aug 20;136(8):1012
pubmed: 32818251
Leuk Res. 2011 Feb;35(2):169-76
pubmed: 20553988
Blood. 2010 Nov 11;116(19):3724-34
pubmed: 20664057
Blood. 1999 Feb 1;93(3):1032-7
pubmed: 9920853